Table: begin end state 1 5 non-cytoplasmic 6 24 transmembrane 25 30 cytoplasmic 31 49 transmembrane 50 60 non-cytoplasmic 61 82 transmembrane 83 102 cytoplasmic 103 123 transmembrane 124 128 non-cytoplasmic 129 149 transmembrane 150 155 cytoplasmic 156 175 transmembrane 176 195 non-cytoplasmic 196 220 transmembrane 221 232 cytoplasmic 233 257 transmembrane 258 263 non-cytoplasmic 264 284 transmembrane 285 322 cytoplasmic 323 341 transmembrane 342 369 non-cytoplasmic 370 387 transmembrane 388 405 cytoplasmic 406 427 transmembrane 428 449 non-cytoplasmic 450 468 transmembrane 469 479 cytoplasmic 480 499 transmembrane 500 504 non-cytoplasmic 505 526 transmembrane 527 537 cytoplasmic 538 558 transmembrane 559 566 non-cytoplasmic
Input: >WP_025163874.1 NCBI__GCF_000498575.2:WP_025163874.1 MSQTMLSILAFVPLVLAGVLLIGFRWPAKYAMPVVFLLTAIIGLTAWDMTLNRVIASSLQ GLILTAAILWIIFGAILLLNTLKHSGGISAIRRGFSSISPDRRVQALIVAWLFGCFIEGA SGFGTPAAVAAPLLVALGFPALAAVILGMMVQSTPVSFGAVGTPMLVGVAGGLDQSGMSA QLLALNSSWDIFFQLIYSRVAITHGLIGILMPLIMLMIMTRFFGKNQSWKEGLMVAPFAI FTGLAFVLPYMAAGVFLGPEFPSMIGAMVGLAIVIPAAKAGFLLPKETWDFADAKDWPAE WMGKLELKIEDIAGKTPISVRMAWAPYLLLAVFLVASRIFPELKAALMAVSFGWTDILGE TGVSGTLQPLYLPGGILCMVVLVTCFLHRMRLAELGAAVSESSRTLLGAGFVLIFTIPMV RILINSGVNASDLMSMPVAMAKLVADSVGGIYPLFAPAVGGLGAFIAGSNTVSNLMLSQF QFNTAGLLGVSGAMMVAAQSVGAAAGNMIAIHNVVAASATVGLLGREGITLRKTMLPTLY YLLAAGALTMIAMYGMAITDPLQVVR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server